SCHEMBL7817547

SCHEMBL7817547

CC(C)(Oc1ccccc1N1CCN(C(=O)c2ccc3ccccc3n2)CC1)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.62
GAA P10253 2/20 0.62
RAB9A P51151 2/20 0.62
ALDH1A1 P00352 2/20 0.62
MAPK1 P28482 2/20 0.62
TSHR P16473 2/20 0.60
GRIN2B Q13224 1/20 0.47
DRD2 P14416 3/20 0.47
DRD3 P35462 3/20 0.47
NPC1 O15118 1/20 0.46
KMT2A Q03164 3/20 0.45
BACE1 P56817 1/20 0.45
MAPT P10636 2/20 0.44
LMNA P02545 2/20 0.44
MEN1 O00255 2/20 0.44
POLB P06746 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7811390 0.83 GAA (0.73) SMN1; SMN2GAARAB9AALDH1A1MAPK1
SCHEMBL7804335 0.82 TSHR (0.67) SMN1; SMN2GAARAB9AALDH1A1MAPK1
SCHEMBL7813944 0.81 MEN1 (0.61) SMN1; SMN2ALDH1A1TSHRDRD2KMT2A
SCHEMBL766164 0.80 GAA (0.70) SMN1; SMN2GAARAB9AALDH1A1MAPK1
SCHEMBL7811604 0.79 SMN1; SMN2 (0.66) SMN1; SMN2GAAALDH1A1TSHRDRD2
SCHEMBL7817548 0.79 USP2 (0.60) GAAALDH1A1TSHRDRD3KMT2A
SCHEMBL27297524 0.77 GAA (1.00) SMN1; SMN2GAARAB9AALDH1A1MAPK1
SCHEMBL7810154 0.77 MEN1 (0.60) SMN1; SMN2ALDH1A1TSHRDRD2KMT2A
SCHEMBL7810142 0.77 POLB (0.60) SMN1; SMN2ALDH1A1TSHRDRD2KMT2A
SCHEMBL7814258 0.76 TSHR (0.61) SMN1; SMN2GAARAB9AALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed